secwatch.observer — SEC 8-K summary
======================================

Issuer:     Syndax Pharmaceuticals Inc (SNDX)
CIK:        0001395937
Form:       8-K
Filed at:   2022-12-07T23:59:59+00:00
Accession:  0001193125-22-300218
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Syndax Pharmaceuticals prices $150M public offering of 6.8M shares at $22.00 per share
--------------------------------------------------------------------------------

- 6,818,182 shares offered at $22.00 each; underwriters have 30-day option for 1,022,727 additional shares.
- Gross proceeds expected ~$150M ($172.5M if option fully exercised).
- Underwriting led by Goldman Sachs, J.P. Morgan, and Cowen; closing expected December 9, 2022.
- Directors, executive officers, and company subject to 60-day lock-up on share sales without consent.
- Offering made under effective shelf registration statement (File No. 333-254661).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1395937/000119312522300218/0001193125-22-300218-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1395937/000119312522300218/d420073d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-300218

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer